Results from the Human Genome Project are enabling scientists to understand how individual cancers form and progress. This information, when combined with newly developed drugs, can optimize the treatment of individual cancers. Joe Gray, director of Berkeley Lab's Life Sciences Division and Associate Laboratory Director for Life and Environmental Sciences, focuses on this approach, its promise, and its current roadblocks - particularly with regard to breast cancer.
No comments:
Write comments